TRMT112P1

Across TCGA pan-cancer cohorts, TRMT112P1 RNA is linked to patient survival in 12 of 34 cancer types, making it the most broadly survival-associated TRMT112P1 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher TRMT112P1 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated TRMT112P1 expression acts as an unfavorable survival marker.

KIRC, SKCM, and CHOL are the cancer types where TRMT112P1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	DFS	Tertile	III,IV	0.527	0.764	<.001	96	view →
SKCM	DFS	Tertile	II,III,IV	0.291	0.577	.002	78	view →
CHOL	DFS	Tertile	All	0.045	0.486	.009	45	view →
UVM	OS	Tertile	All	0.248	0.769	.007	36	view →
CESC	OS	Tertile	IV	0.121	0.591	.029	36	view →
KIRP	OS	Tertile	III,IV	0.220	0.810	<.001	36	view →
ESCA	OS	Tertile	II,III,IV	0.103	0.868	<.001	18	view →
LUAD	OS	Tertile	All	0.258	0.787	.018	18	view →
SARC	OS	Tertile	All	0.108	0.827	<.001	18	view →
THCA	DFS	Tertile	All	0.205	0.814	.035	9	view →
LIHC	OS	Tertile	All	0.473	0.786	.045	9	view →
BRCA	OS	Tertile	II,III,IV	0.192	0.566	.036	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 12 lineages.

TRMT112P1–KIRC (DFS)

Open the KIRC breakdown →